Infections Rise in Mongolia, Where Sinopharm Is the Main Vaccine

The New York Times | June 9, 2021, 5:26 a.m. | Original

The nation reported more than 1,300 new coronavirus infections on Wednesday, renewing a focus on the effectiveness of the Chinese-made Sinopharm shots.

Biden Aims to Bolster U.S. Alliances in Europe, but Challenges Loom In Germany, the key to everyday freedoms is a rapid virus test.